CaMKII dysregulation has been implied in several neurological and neurodegenerative diseases (Chia et al., 2018; Cook et al., 2019; Liu and Murray, 2012; Picconi et al., 2004) and has recently gained attention in neuropsychiatric disorders like schizophrenia (Frankland et al., 2008; Robison, 2014). This evidence concerns the gene CAMK2G and schizophrenia.